415 related articles for article (PubMed ID: 22925316)
1. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
3. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
Eraković Haber V; Bosnar M; Kragol G
Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
Altenburg J; de Graaff CS; van der Werf TS; Boersma WG
Respiration; 2011; 81(1):75-87. PubMed ID: 20733282
[TBL] [Abstract][Full Text] [Related]
5. Role of long term antibiotics in chronic respiratory diseases.
Suresh Babu K; Kastelik J; Morjaria JB
Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
[TBL] [Abstract][Full Text] [Related]
6. Macrolides and airway inflammation in children.
Shinkai M; Rubin BK
Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
[TBL] [Abstract][Full Text] [Related]
7. Long-term macrolide treatment for chronic respiratory disease.
Spagnolo P; Fabbri LM; Bush A
Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
[TBL] [Abstract][Full Text] [Related]
8. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
López-Boado YS; Rubin BK
Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
[TBL] [Abstract][Full Text] [Related]
9. [Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases].
Sacre Hazouri JA
Rev Alerg Mex; 2006; 53(3):108-22. PubMed ID: 16970113
[TBL] [Abstract][Full Text] [Related]
10. Chronic macrolide therapy in inflammatory airways diseases.
Friedlander AL; Albert RK
Chest; 2010 Nov; 138(5):1202-12. PubMed ID: 21051396
[TBL] [Abstract][Full Text] [Related]
11. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
Swords WE; Rubin BK
Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
[TBL] [Abstract][Full Text] [Related]
12. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
13. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
[TBL] [Abstract][Full Text] [Related]
14. Long-term macrolide therapy in chronic inflammatory airway diseases.
Crosbie PA; Woodhead MA
Eur Respir J; 2009 Jan; 33(1):171-81. PubMed ID: 19118228
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of macrolides as anti-inflammatories in respiratory diseases].
Sevilla-Sánchez D; Soy-Muner D; Soler-Porcar N
Arch Bronconeumol; 2010 May; 46(5):244-54. PubMed ID: 19962815
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma.
Hrvacić B; Bosnjak B; Bosnar M; Ferencić Z; Glojnarić I; Eraković Haber V
Eur J Pharmacol; 2009 Aug; 616(1-3):236-43. PubMed ID: 19560456
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics as immunomodulant agents in COPD.
Blasi F; Mantero M; Aliberti S
Curr Opin Pharmacol; 2012 Jun; 12(3):293-9. PubMed ID: 22321568
[TBL] [Abstract][Full Text] [Related]
18. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
19. The role of atypical infections and macrolide therapy in patients with asthma.
Rollins DR; Good JT; Martin RJ
J Allergy Clin Immunol Pract; 2014; 2(5):511-7. PubMed ID: 25213043
[TBL] [Abstract][Full Text] [Related]
20. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
Crowley S; Egan JJ
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
